An impairment loss of approximately 400 million yen is expected to be recorded in the fiscal year ending March 2026. The consolidated earnings guidance has been revised to net sales of 62 billion yen (up 1.3% from the previous forecast), operating income of 1.45 billion yen (down 9.4%), and net income attributable to owners of the parent of 50 million yen (down 92.9%).<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"5988","jir_company_name":"Pyorax Corporation","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-04-27","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/04\/5988-20260427-01.pdf","jir_short_summary":"An impairment loss of approximately 400 million yen is expected to be recorded in the fiscal year ending March 2026. The consolidated earnings guidance has been revised to net sales of 62 billion yen (up 1.3% from the previous forecast), operating income of 1.45 billion yen (down 9.4%), and net income attributable to owners of the parent of 50 million yen (down 92.9%).","jir_summary":"### Regarding the Recording of Impairment Loss\nIn the consolidated financial results for the fiscal year ending March 2026, some overseas subsidiaries experienced deteriorated profitability due to changes in the business environment, and indicators of impairment on fixed assets were identified. Consequently, an impairment loss of approximately 400 million yen is expected to be recorded. This impairment loss is a one-time item and will not have a continuing impact on performance from the following fiscal year onward.\n\n### Regarding the Revision of Earnings Guidance\nThe consolidated earnings guidance for the fiscal year ending March 2026 has been revised. Net sales are expected to increase to 62,000 million yen (up 1.3% from the previous forecast), while operating income is forecasted at 1,450 million yen (down 9.4%), ordinary income at 1,400 million yen (down 6.7%), and net income attributable to owners of the parent drastically declining to 50 million yen (down 92.9%). The main factors include the recording of the impairment loss, review of provisions and tax expenses, impact of sales trends in the automotive industry among major clients, and increased variable costs. The year-end dividend forecast remains unchanged at 53 yen.","jir_financial_highlights":"Impairment Loss: Approximately 400 million yen (One-time factor with no ongoing impact on performance from the following fiscal year)\nNet Sales: 62,000 million yen (Up 1.3% compared to previous forecast)\nOperating Income: 1,450 million yen (Down 9.4% compared to previous forecast)\nOrdinary Income: 1,400 million yen (Down 6.7% compared to previous forecast)\nNet Income Attributable to Owners of Parent: 50 million yen (Down 92.9% compared to previous forecast)\nEarnings Per Share: 1.96 yen (Unknown)\nYear-End Dividend Forecast: 53 yen (No change from previous forecast)","jir_category":"","jir_hashtags":"#Pyorax, #EarningsGuidanceRevision, #JapaneseStocks","jir_key_figures":"Impairment Loss: Approximately 400 million yen (expected to be recorded in fiscal year ending March 2026)\nNet Sales: 62,000 million yen (up 1.3% compared to previous forecast)\nNet Income Attributable to Owners of Parent: 50 million yen (down 92.9% compared to previous forecast)","jir_meta_title":"[Pyorax] Downward Revision of Earnings Guidance for Fiscal Year Ending March 2026 | Recording of Impairment Loss Approx. 400 Million Yen","jir_meta_description":"Pyorax will record an impairment loss of approximately 400 million yen for the fiscal year ending March 2026 and has revised consolidated earnings guidance to net sales of 62 billion yen, operating income of 1.45 billion yen, and net income of 50 million yen. Dividend remains unchanged at 53 yen.","jir_og_title":"[Pyorax] Downward Revision of Earnings Guidance for Fiscal Year Ending March 2026 | Recording of Impairment Loss Approx. 400 Million Yen","jir_og_description":"Pyorax revises its earnings forecast for the fiscal year ending March 2026. Due to recording an impairment loss of approximately 400 million yen, net income is expected to decline sharply. Dividend remains unchanged.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[{\"jir_chart_id\": \"guidance_comparison\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Comparison of Consolidated Earnings Guidance Before and After Revision for Fiscal Year Ending March 2026\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Net Sales\\\",\\\"Operating Income\\\",\\\"Ordinary Income\\\",\\\"Net Income Attributable to Owners of Parent\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Previous Forecast\\\",\\\"data\\\":[61200,1600,1500,700],\\\"backgroundColor\\\":\\\"rgba(54,162,235,0.5)\\\"},{\\\"label\\\":\\\"Revised Forecast\\\",\\\"data\\\":[62000,1450,1400,50],\\\"backgroundColor\\\":\\\"rgba(255,99,132,0.5)\\\"}]},\\\"options\\\":{\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}},\\\"plugins\\\":{\\\"legend\\\":{\\\"position\\\":\\\"top\\\"}}}}\"}]","ir_related_company":17092,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"earnings_guidance","footnotes":""},"sector":[],"importance":[],"class_list":["post-42906","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n